Login to Your Account



Pharma: Other News To Note


Thursday, June 28, 2012
• Eisai Inc., of Woodcliff Lake, N.J., said that following the approval of its first product, Zonegran (zonisamide) indicated in the treatment of epilepsy, it is expanding its operations into Russia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription